Literature DB >> 15224300

Clopidogrel-associated autoimmune thrombocytopenic purpura.

Patricia J M Best1, Verghese Mathew, Svetomir N Markovic.   

Abstract

We report the case of a 51-year-old male who underwent coronary stent placement for the treatment of an acute myocardial infarction. One week later, he developed symptomatic autoimmune thrombocytopenia likely related to clopidogrel use. This was successfully treated with intravenous methylprednisilone and platelet transfusions. Copyright 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15224300     DOI: 10.1002/ccd.20046

Source DB:  PubMed          Journal:  Catheter Cardiovasc Interv        ISSN: 1522-1946            Impact factor:   2.692


  3 in total

1.  Profound thrombocytopenia induced by clopidogrel with a prior history of long-term safe administration.

Authors:  Yuan-Lin Guo; Jian-Jun Li; Jin-Qing Yuan; Xue-Wen Qin; Xin Zheng; Chao-Wei Mu; Yi-Hong Hua
Journal:  World J Cardiol       Date:  2010-06-26

2.  The change in platelet count in patients with acute coronary syndrome 6 months after coronary stent implantation.

Authors:  Zhanqiang Zhang; Lihong An; Dayong Du; Xiaohui Lai; Fang Wang; Yuntian Li
Journal:  Blood Coagul Fibrinolysis       Date:  2015-09       Impact factor: 1.276

3.  Early profound secondary autoimmune thrombocytopenia induced by clopidogrel in a patient with a coronary artery stent.

Authors:  Volkan Karakuş; Burak Deveci; Erdal Kurtoğlu; Sakir Arslan
Journal:  Turk J Haematol       Date:  2012-03-05       Impact factor: 1.831

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.